| [1] |
Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol, 2013, 10: 330-344.
|
| [2] |
Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care, 2007, 30: 1212-1218.
|
| [3] |
Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasie diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol, 2014, 20: 475-485.
|
| [4] |
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia, 2016, 59: 1121-1140.
|
| [5] |
Longo R, Ricci C, Masutti F, et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol, 1993, 28: 297-302.
|
| [6] |
Thomsen C, Becker U, Winkler K, et al. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging, 1994, 12: 487-495.
|
| [7] |
Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging, 1995, 5: 281-285.
|
| [8] |
Kullberg J, Ortiz-Nieto F, Johansson L. Reproducibility of hepatic triglyceride content assessment in normals using localized magnetic resonance spectroscopy. Diabetes Obes Metab, 2009, 11: 516-518.
|
| [9] |
Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab, 2005, 288: E462-E468.
|
| [10] |
van Werven JR, Schreuder TC, Nederveen AJ, et al. Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy. Eur J Radiol, 2010, 75: e102-e107.
|
| [11] |
Gan LT, Van Rooyen DM, Koina ME, et al. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. J Hepatol, 2014, 61: 1376-1384.
|
| [12] |
Min HK, Kapoor A, Fuchs M, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab, 2012, 15: 665-674.
|
| [13] |
Thelwall PE, Smith FE, Leavitt MC, et al. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance. J Hepatol, 2013, 59: 543-549.
|
| [14] |
Corbin IR, Furth EE, Pickup S, et al. In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy. Biochim Biophys Acta, 2009, 1791: 757-763.
|
| [15] |
McPherson S, Jonsson JR, Cowin GJ, et al. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol, 2009, 51: 389-397.
|
| [16] |
Banerjee R, Pavlides M, Tunnicliffe EM, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol, 2014, 60: 69-77.
|
| [17] |
Georgoff P, Thomasson D, Louie A, et al. Hydrogen-1 MR Spectroscopy for Measurement and Diagnosis of Hepatic Steatosis. AJR Am J Roentgenol, 2012, 199: 2-7.
|
| [18] |
Urdzik J, Bjerner T, Wanders A, et al. The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasis. J Hepatol, 2012, 56: 640-646.
|
| [19] |
韩芳, 万凯明, 韩敏, 等. 1H-MRS测定肝脂肪含量在非酒精性脂肪肝肝纤维化趋势中的应用价值. 中华临床医师杂志(电子版), 2012, 6: 6246-6249.
|
| [20] |
Ryan MC, Itsiopoulos C, Thodis T, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol, 2013, 59: 138-143.
|
| [21] |
Granér M, Nyman K, Siren R, et al. Ectopic Fat Depots and Left Ventricular Function in Nondiabetic Men With Nonalcoholic Fatty Liver Disease. Circulation: Cardiovasc Imaging, 2014, 8: e001979-e001979.
|
| [22] |
Lomonaco R, Bril F, Portillo-Sanchez P, et al. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes. Diabetes Care, 2016, 39: 632-638.
|
| [23] |
van Werven JR, Hoogduin JM, Nederveen AJ, et al. Reproduci-bility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content.J Magn Reson Imaging, 2009, 30: 444-448.
|
| [24] |
Otvos JD. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab, 2002, 48: 171-180.
|
| [25] |
Abrigo JM, Shen J, Wong VW, et al. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study. J Hepatol, 2014, 60: 809-815.
|
| [26] |
Valkovicˇ L, Gajdoík M, Traussnigg S, et al. Application of localized 31P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease. Eur Radiol, 2014, 24: 1602-1609.
|
| [27] |
Chabanova E, Bille DS, Thisted E, et al. 1H MRS assessment of hepatic steatosis in overweight children and adolescents: comparison between 3T and open 1T MR-systems. Abdom Imaging, 2013, 38: 315-319.
|
| [28] |
Kinner S, Reeder SB, Yokoo T. Reeder and T. Yokoo, Quantitative Imaging Biomarkers of NAFLD. Dig Dis Sci, 2016.
|
| [29] |
Le TA, Chen J, Changchien C, et al. Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology, 2012, 56: 922-932.
|
| [30] |
Bannas P, Kramer H, Hernando D, et al. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers. Hepatology, 2015, 62: 1444-1455.
|
| [31] |
Zand KA, Shah A, Heba E, et al. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children. J Magn Reson Imaging, 2015, 42: 1223-1232.
|
| [32] |
Heba ER, Desai A, Zand KA, et al. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging, 2016, 43: 398-406.
|
| [33] |
Satkunasingham J, Besa C, Bane O, et al. Liver fat quantification: Comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy. Eur J Radiol, 2015, 84: 1452-1458.
|
| [34] |
Noureddin M, Lam J, Peterson MR, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology, 2013, 58: 1930-1940.
|
